Cargando…
GDMT for heart failure and the clinician's conundrum
Therapeutic advances in management of CHF have decreased mortality and have impacted progression in patients with mild to moderate heart failure. Aggressive campaigns by cardiology societies aimed at increasing implementation of these measures in routine practices have almost generalized the treatme...
Autor principal: | Samarendra, Padmaraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906979/ https://www.ncbi.nlm.nih.gov/pubmed/31524968 http://dx.doi.org/10.1002/clc.23268 |
Ejemplares similares
-
Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
por: Jarjour, Marilyne, et al.
Publicado: (2023) -
Diagnosing Lyme Carditis Presenting With Complete Heart Block
por: Samarendra, Padmaraj, et al.
Publicado: (2020) -
The cardiac enigma: current conundrums in heart failure research
por: Kapiloff, Michael S., et al.
Publicado: (2016) -
A Precipitous Decision: Transcatheter Aortic Valve Replacement in Low-Risk Patients
por: Samarendra, Padmaraj
Publicado: (2020) -
Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials
por: Dixit, Neal M., et al.
Publicado: (2023)